Newly Formed European Thrombosis & Haemostasis Alliance Calls for Patient Safety & Research Strategy
The European Thrombosis and Haemostasis Alliance (ETHA) has been recently formed to advocate for better awareness and prioritisation of thrombosis and haemostasis in European Union (EU) patient safety and research programmes.
ETHA, with its 21 national thrombosis and haemostasis society members, has a united focus on better addressing thrombosis, also known as clotting, and improving the understanding of haemostasis. ETHA stands to work with the public and decision-makers to share expertise in clotting and bleeding disorders, elevate patient-centric policies and promote improved outcomes in the EU. As an initial area of priority, ETHA is highlighting the urgent need to better understand the condition of thrombosis.
Share this post, choose a platform
Related Campaign News
New theme underscores the critical link between thrombosis and other conditions [...]
No longer alone: Jo’s mission to transform TTP support and advocacy [...]
A new study published in The Lancet Respiratory Medicine provides critical [...]
